Bringing together researchers, clinicians and educators with the vision to create and disseminate new knowledge on pain to optimise patient outcomes.
_self
h2
Become a member
cmp-call-to-action--ochre
The Sydney Pain Consortium is a multidisciplinary network of scientists, clinicians and educators that provides a leading voice in pain research that translates into optimal clinical service delivery nationally and internationally. The fostering of existing and the creating of new collaborations is a core role of the Sydney Pain Consortium
The Sydney Pain Consortium’s focus is to determine the underlying mechanisms responsible for transient and persistent pain and medication dependency and to translate these findings into clinical practice, education, policy and community awareness.Â
The ±¬ÁÏÍõ is the 7th leading institution internationally in pain related research and number one in Australia.
50
automatic
LinkAssociate Professor
Fereshteh Pourkazemi is a physiotherapist, researcher, and academic at the ±¬ÁÏÍõ, and the current Convenor of the Sydney Pain Consortium. Her work focuses on improving the lives of people with chronic and complex pain through interdisciplinary research, education, and creative practices focused on social interventions. She has led the development of innovative arts-in-health projects that reframe pain experiences, and is actively building collaborative networks across research, clinical practice, and the community. As Convenor, she is shaping the Consortium’s vision, with a focus on capacity-building, equity, and translating pain research into meaningful impact.
 is an Associate Professor in Neuroscience, School of Medical Sciences based at the Brain and Mind Centre, ±¬ÁÏÍõ.
She has been awarded competitive research funding in projects across the clinical neurosciences, with research involvement in toxic, metabolic, immune-mediated and painful neuropathies and motor neuron diseases.Â
She has expertise in multidisciplinary peripheral neuropathy research, leading studies examining clinical translation, assessment strategies, treatment and risk factors for chemotherapy-induced peripheral neuropathy.Â
 is a neurobiologist currently working as a Senior Research Fellow at the ±¬ÁÏÍõ Pain Management Research Institute.
Karin's research team is currently working on 2 main projects. The first trying to understand how a small population of cells in the midbrain affect responses to pain, and the second focused on a circuit that may link pain and sleep circuits. Both projects are ultimately aimed at finding new ways to improve the lives of people who suffer from chronic pain conditions.
Karin is a co-writer in the recent publication .
 is an early career researcher (ECR) investigating the underlying neurobiology of episodic and chronic migraine.
Her current research projects are focused on central changes associated with chronic migraine, particularly the activity of the hypothalamus and endogenous analgesic circuit.
Of further interest, is the nature of the activity in these regions following successful and unsuccessful CGRP inhibitor treatment
Dr  is a mid-career neuroscientist currently working as a Senior Lecturer and Laboratory Head at the ±¬ÁÏÍõ School of Pharmacy. She is also affiliated with the Pain Management Research Institute and Kolling Institute at the Royal North Shore Hospital.
Bryony’s research focuses on two main projects, the first is understanding how chronic pain alters brain regions linked to pain comorbidities such as anxiety, depression and cognitive impairments. She is also interested in understanding how endogenous analgesic circuits are altered in chronic pain. The second project is understanding the neuronal circuits that underlie the phenomenon of ‘incubation of craving’ in alcohol use disorder, which intriguingly involves brain regions that intersect with pain processing.
